Development of a consensus-based risk stratification algorithm for HR+/HER2- early breast cancer to guide adjuvant CDK4/6i therapy: Outcomes from a multidisciplinary workshop in India

Experts developed a consensus-based algorithm to improve recurrence risk stratification and guide treatment decisions in patients with HR+ HER2- early breast cancer. Prospective and real-world validation is needed to establish the framework’s clinical utility.